CSPC Pharma HKG:1093 – Hong Kong Blue Chip stock
Blue Chip Stock CSPC Pharma HKG:1093 August 2020 the first Interim Dividend was announced. For CSPC Pharma Dividend Growth and Safety look promising, but is this a dividend stock that will keep growing? It did for the last 5 years. Well with a P/E and Price-to-book ratios like this, the price seems higher than the value of this stock.
Updated: November 3, 2025
Ex Dividend: N/A
Stock Value Score Card
This score shows you at a glance whether the stock is currently undervalued, fairly priced, or expensive — based on 7 key value metrics like P/E, P/B and Free Cash Flow.
- Price-to-Earnings (P/E ratio): 20.68
- Price-to-Book ratio: 2.53 (preferably <3 is acceptable for value investors)
- Earnings per Share (EPS): 0.37
- BETA: 0.57
A Beta above 1.0 may indicate higher volatility than the market.
A Beta below 1.0 may indicate greater price stability and faster bounce back.
Champion Members see the full 3-Pillar Score Card: Dividend Growth, Dividend Safety, and Stock Value — for faster, smarter stock selection.
